| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $175.8M | +100.3% |
| SG&A Expense | $32.2M | +26.9% |
| Operating Income | -$208.0M | -83.8% |
| Pre-tax Income | -$192.9M | -77.9% |
| Net Income | -$193.0M | -78.0% |
| EPS (Basic) | -$3.30 | -59.4% |
| EPS (Diluted) | -$3.30 | -59.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.6M | -20.4% |
| Short-term Investments | $200.6M | -20.7% |
| Current Assets | $264.3M | -20.1% |
| Total Assets | $277.7M | -25.2% |
| Current Liabilities | $22.3M | +36.1% |
| Total Liabilities | $33.8M | +92.9% |
| Stockholders' Equity | $243.9M | -31.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$166.5M | -68.6% |
| Capital Expenditures | $514K | +86.9% |
| Investing Cash Flow | $100.9M | +234.7% |
| Financing Cash Flow | $53.3M | -68.2% |
| Free Cash Flow | -$167.0M | -68.6% |